UNSPSC 51422435: Hydrocortisone tebutate

This classification denotes an anti-inflammatory agent C27H40O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FXJ67LWZ4S, chemically known as cortisol, 21-(3,3-dimethylbutyrate), but more generally known as hydrocortisone tebutate, which bears US NIH Compound Identifier 23424017. Most nations, for tariff and trade purposes, schedule hydrocortisone tebutate under HS 29372100 and SITC 54153. As of Q4 2014, HYDROCORTISONE TEBUTATE remains US FDA's Preferred Term for this commodity.

SMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CC(C)(C)C)O)C)O.

UNSPSC 51422435 Hydrocortisone tebutate is a Commodity code representing a corticosteroid pharmaceutical used in dermatological and anti-inflammatory applications. However, recent state and local procurement activity under this code does not reflect the pharmaceutical scope; instead, the single recent opportunity on record involves emergency medical supplies wholly unrelated to hydrocortisone tebutate, indicating a tagging mismatch between the code assignment and the actual goods being procured.

Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required electronic submission by July 26, 2023, at 2:00 pm, with vendors responsible for all shipping and delivery costs and subject to drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and a three-month probationary termination clause. The contract was structured as a two-year term with an optional one-year renewal, with potential FEMA funding introducing Clean Air Act and Federal Water Pollution Control Act compliance requirements. The code shows no meaningful recent activity aligned with its stated pharmaceutical scope; state and local buyers evaluating hydrocortisone tebutate procurement should treat this code as inactive or incorrectly tagged and source opportunities through alternative pharmaceutical or medical-supply classification codes.